Health Innovations Pharmacy Recalls Estriol 5% Cream Due to Sterility Concerns
Health Innovations Pharmacy is recalling Estriol 5% Cream Vaginal Cream because inspection observations indicate a lack of assurance regarding sterility and stability data.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a risk to sterility and quality assurance for a medical product, which fits the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.
Plain-English summary
Health Innovations Pharmacy, Inc. is recalling Estriol 5% Cream Vaginal Cream. The recall is being conducted due to recent inspection observations associated with certain quality control procedures. These observations present a risk to sterility and quality assurance, and the available stability data does not support the product's expiry date.
The recall covers all lots of the product. The distribution pattern is listed as North Carolina (NC). The source text does not specify the number of units affected or the specific dates of distribution.
Consumers who have this product should stop using it and contact Health Innovations Pharmacy at (910) 246-5155 for further instructions. The company is located at 295 Pinehurst Ave, Southern Pines, NC 28387.
The recalled product
- Product
- Estriol 5% Cream Vaginal Cream, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155
- Manufacturer
- Health Innovations Pharmacy, Inc
- Category
- Drug — Topical Steroid/Hormone
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 65 recalled by Health Innovations Pharmacy, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 65 products in this recall →Related recalls
Same manufacturer · Health Innovations Pharmacy, Inc
See all →- ModerateCarvedilol 1.25 mg/mL Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighProgest Cream Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighHealth Innovations Pharmacy Recalls Phospholine Iodide Eye Drops
FDA (Drugs) · 2015-05-20
- HighNortriptyline Suspension Recalled for Sterility and Stability Concerns
FDA (Drugs) · 2015-05-20
- HighHealth Innovations Pharmacy Recalls Naltrexone Capsules Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
Same hazard · sterility risk
See all →- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereFDA Recalls Rohto Dry-Aid Eye Drops Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighMedline Medical Procedure Kits Recalled for High Endotoxin Levels
FDA (Devices) · 2026-05-06
- HighCook Medical tracheostomy introducer sets labeled with overstated expiration dates
FDA (Devices) · 2026-04-15
Similar recalls
- HighEstriol Vaginal Cream Recalled Due to Insanitary Manufacturing Conditions
FDA (Drugs) · 2022-07-13
- HighEstriol Vaginal Cream Recalled for Insanitary Manufacturing Conditions
FDA (Drugs) · 2022-07-13
- High
- HighLife Science Pharmacy Recalls Compounded Estriol Vaginal Creams
FDA (Drugs) · 2015-12-09
- HighInjectable Glycerin Sterile Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-02-01
- HighInjectable Ethyl Alcohol 95% Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2023-02-01